Fluorescent biosensor designs. A. MeroCBD, biosensor of endogenous Cdc42 activation. Here a fragment of Wiskott Aldrich syndrome protein (WASP) that binds only to activated Cdc42 is covalently derivatized with an environmentally sensitive dye. When the WASP fragment encounters and binds to activated Cdc42, the solvation of the dye by water is reduced, leading to a fluorescence change. Advantages of this design include the ability to study endogenous protein, and enhanced sensitivity due to direct excitation of a bright, long wavelength dye (as opposed to indirect excitation via FRET). The disadvantage is the need for microinjection, electroporation or some other means to `load' the covalently tagged protein biosensor into cells. B. RhoA biosensor. Here a fragment of Rhotekin that binds only to activated RhoA is attached to RhoA as part of the same protein chain. Two different fluorescent proteins undergoing FRET are in the chain between RhoA and the Rhotekin fragment, such that binding of the fragment to activated RhoA alters the distance and/or orientation between the fluorescent proteins, affecting FRET. This biosensor is fully genetically encoded, greatly simplifying loading into the cell. Because the Rhotekin fragment is attached to the RhoA, image processing is simplified relative to the dual chain sensor shown in C (see text). C. Rac1 FLAIR, biosensor of Rac1 activation. This design is similar to that of the RhoA biosensor, but here the PAK fragment used to bind activated Rac1 is not part of the same chain as the Rac1. The use of a dual chain, intermolecular FRET design enhances sensitivity because, unlike the single chain design, there is no FRET when the biosensor is in the `off' state. Additional image processing (bleedthrough correction) is required because the biosensor components can distribute differently throughout the cell.